BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7496617)

  • 21. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension.
    Zeiher AM; Drexler H; Saurbier B; Just H
    J Clin Invest; 1993 Aug; 92(2):652-62. PubMed ID: 8349804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial modulation of coronary vasomotor tone in humans. Effects of atherosclerosis and risk factors for coronary artery disease.
    Zeiher AM
    Arzneimittelforschung; 1994 Mar; 44(3A):439-42. PubMed ID: 8185719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women.
    El-Magadmi M; Bodill H; Ahmad Y; Durrington PN; Mackness M; Walker M; Bernstein RM; Bruce IN
    Circulation; 2004 Jul; 110(4):399-404. PubMed ID: 15262847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adventitial dysfunction: an evolutionary model for understanding atherosclerosis.
    Yun AJ; Doux JD; Bazar KA; Lee PY
    Med Hypotheses; 2005; 65(5):962-5. PubMed ID: 16117998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenic mechanisms of atherosclerosis: effect of lipid lowering on the biology of atherosclerosis.
    Ganz P; Creager MA; Fang JC; McConnell MV; Lee RT; Libby P; Selwyn AP
    Am J Med; 1996 Oct; 101(4A):4A10S-16S. PubMed ID: 8900332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences].
    Patti G; Melfi R; Di Sciascio G
    Recenti Prog Med; 2005 Oct; 96(10):499-507. PubMed ID: 16491775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral consequences of hypertension: where do they lead?
    Spence JD
    J Hypertens Suppl; 1996 Dec; 14(5):S139-45. PubMed ID: 9120671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-atherosclerotic action of hypotensive drugs].
    Gmiński J; Stajszczyk M
    Wiad Lek; 1996; 49(7-12):182-98. PubMed ID: 9245114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hypertension and endothelial dysfunction].
    Zoghi M; Nalbantgil I
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):142-7, AXVIII. PubMed ID: 12134540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypertension and vascular diseases: molecular and cellular mechanisms].
    Lüscher TF
    Schweiz Med Wochenschr; 1995 Feb; 125(7):270-82. PubMed ID: 7878405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homocysteine, endothelial dysfunction, and coronary artery disease: emerging strategy for secondary prevention.
    Woo KS; Qiao M; Chook P; Poon PY; Chan AK; Lau JT; Fung KP; Woo JL
    J Card Surg; 2002; 17(5):432-5. PubMed ID: 12630544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of bone marrow-derived vascular progenitor cells leads to inflammation and atherosclerosis.
    Goldschmidt-Clermont PJ
    Am Heart J; 2003 Oct; 146(4 Suppl):S5-12. PubMed ID: 14564300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Atherosclerosis].
    Ter Arkh; 1990; 62(8):7-21. PubMed ID: 2274875
    [No Abstract]   [Full Text] [Related]  

  • 34. An urgent matter-identifying your patients' cardiovascular risk and improving their outcomes. Atherosclerosis: the underlying disease.
    Tóth PP
    J Fam Pract; 2009 Nov; 58(11 Suppl Urgent):S19-25. PubMed ID: 19891944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of fluid dynamic factors in the development and progression of atherosclerosis, thrombosis and aneurysms].
    Goldsmith HL; Karino T
    Vasa Suppl; 1991; 32():14-7. PubMed ID: 1771483
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemodynamic effects on atherosclerosis and thrombosis.
    Eskin SG; McIntire LV
    Semin Thromb Hemost; 1988 Apr; 14(2):170-4. PubMed ID: 3206234
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathogenesis of atherosclerosis.
    Ylä-Herttuala S; Luoma J; Kallionpää H; Laukkanen M; Lehtolainen P; Viita H
    Maturitas; 1996 May; 23 Suppl():S47-9. PubMed ID: 8865139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oxidative stress and endothelial dysfunction].
    Jarasūniene D; Simaitis A
    Medicina (Kaunas); 2003; 39(12):1151-7. PubMed ID: 14704502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The peripheral vascular response to exercise is impaired in patients with risk factors for coronary artery disease.
    Chenzbraun A; Levin G; Scheffy J; Keren A; Stern S; Goor D
    Cardiology; 2001; 95(3):126-30. PubMed ID: 11474157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathogenesis of vasoplastic stenocardia: the role of arteriosclerosis and the endothelium].
    Zateĭshchikov DA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(2):120-7. PubMed ID: 3322324
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.